CANCERLINQ Trademark

Trademark Overview

On Wednesday, January 25, 2012, a trademark application was filed for CANCERLINQ with the United States Patent and Trademark Office. The USPTO has given the CANCERLINQ trademark a serial number of 85524713. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, November 25, 2021. This trademark is owned by American Society of Clinical Oncology, Inc.. The CANCERLINQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information in the field of neoplastic disease prevention, screening, diagnosis and treatment for use by physicians and other health care providers in the field of neoplastic diseases; providing patient information in the field of neoplastic diseases

Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; providing quality assurance services in the field of healthcare, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare quality data and preparing reports in connection therewith for the purpose of analyzing the quality of cancer care and treatment
cancerlinq

General Information

Serial Number85524713
Word MarkCANCERLINQ
Filing DateWednesday, January 25, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, November 25, 2021
Registration Number4960466
Registration DateTuesday, May 17, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2015

Trademark Statements

Pseudo MarkCANCER LINK
Goods and ServicesProviding information in the field of neoplastic disease prevention, screening, diagnosis and treatment for use by physicians and other health care providers in the field of neoplastic diseases; providing patient information in the field of neoplastic diseases
Goods and ServicesProviding medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; providing quality assurance services in the field of healthcare, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare quality data and preparing reports in connection therewith for the purpose of analyzing the quality of cancer care and treatment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 21, 2012
Primary Code042
First Use Anywhere DateFriday, March 18, 2016
First Use In Commerce DateFriday, March 18, 2016
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 28, 2012
Primary Code044
First Use Anywhere DateFriday, March 18, 2016
First Use In Commerce DateFriday, March 18, 2016

Trademark Owner History

Party NameCANCERLINQ LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressCAMBRIDGE, MA 02138
Party NameAmerican Society of Clinical Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlexandria, VA 22314
Party NameAmerican Society of Clinical Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlexandria, VA 22314
Party NameAmerican Society of Clinical Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlexandria, VA 22314

Trademark Events

Event DateEvent Description
Thursday, November 8, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 28, 2012NEW APPLICATION ENTERED
Saturday, January 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 31, 2012NOTICE OF PSEUDO MARK MAILED
Thursday, May 3, 2012ASSIGNED TO EXAMINER
Tuesday, May 8, 2012NON-FINAL ACTION WRITTEN
Tuesday, May 8, 2012NON-FINAL ACTION E-MAILED
Tuesday, May 8, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 19, 2013DIVISIONAL PROCESSING COMPLETE
Tuesday, February 19, 2013ATTORNEY REVIEW COMPLETED
Friday, November 16, 2012ASSIGNED TO LIE
Wednesday, November 21, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 21, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 29, 2012SUSPENSION LETTER WRITTEN
Thursday, November 29, 2012LETTER OF SUSPENSION E-MAILED
Thursday, November 29, 2012NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 29, 2013TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 29, 2013DIVISIONAL REQUEST RECEIVED
Wednesday, February 13, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 3, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 9, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 11, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 11, 2014REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, May 14, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 21, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 21, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2016USE AMENDMENT FILED
Sunday, April 10, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, April 11, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 12, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 10, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 30, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 30, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 24, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, February 24, 2016SOU EXTENSION 1 FILED
Saturday, March 12, 2016SOU EXTENSION 1 GRANTED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 6, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 17, 2016REGISTERED-PRINCIPAL REGISTER
Monday, May 17, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 24, 2021TEAS SECTION 8 & 15 RECEIVED
Thursday, November 25, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 25, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, November 25, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 31, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, May 17, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 7, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

cancerlinq providing field medical neoplastic diseases information quality scientific research analyzing